Pharming Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharming Group and other ETFs, options, and stocks.About PHAR
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.
CEOFabrice Chouraqui
CEOFabrice Chouraqui
Employees—
Employees—
HeadquartersLeiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded1988
Founded1988
Employees—
Employees—
PHAR Key Statistics
Market cap1.18B
Market cap1.18B
Price-Earnings ratio1.17K
Price-Earnings ratio1.17K
Dividend yield—
Dividend yield—
Average volume25.51K
Average volume25.51K
High today$17.63
High today$17.63
Low today$16.72
Low today$16.72
Open price$16.83
Open price$16.83
Volume17.18K
Volume17.18K
52 Week high$17.76
52 Week high$17.76
52 Week low$7.31
52 Week low$7.31
Stock Snapshot
Pharming Group(PHAR) stock is priced at $17.00, giving the company a market capitalization of 1.18B. It carries a P/E multiple of 1167.36.
As of 2025-11-16, Pharming Group(PHAR) stock has fluctuated between $16.72 and $17.63. The current price stands at $17.00, placing the stock +1.7% above today's low and -3.6% off the high.
The Pharming Group(PHAR)'s current trading volume is 17.18K, compared to an average daily volume of 25.51K.
During the past year, Pharming Group(PHAR) stock moved between $7.31 at its lowest and $17.76 at its peak.
During the past year, Pharming Group(PHAR) stock moved between $7.31 at its lowest and $17.76 at its peak.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%